The company held a performance appraisal experience exchange meeting
Release time:
2020-08-14
How to grasp the "bull nose" of internal management "?
runs through the whole management process with new ideas and new thinking
company holds performance appraisal experience exchange meeting
report performance appraisal is a key point for enterprises to strengthen internal management. how to grasp this" bull nose "and make it play its due role better? 11 April 16 , the group company held a special experience exchange meeting to share experiences and make requests on this topic.
The exchange meeting was presided over by Xiang Chongping, deputy general manager of the group company. The heads of the group's functional departments and subordinate units and relevant management personnel attended the meeting. Daye Peak, Pharmaceutical Jinxi Factory, International Trade Company and Cable Company, as representatives of enterprises, introduced their experience in performance management. Due to the different nature and industry of each unit, internal management also has different emphasis, which is reflected in the performance appraisal, and also has different management methods and forms. After sharing the experience, Yu Jianhong, general manager of the group company, analyzed and expounded the importance of performance appraisal and incentive mechanism in enterprise management from the aspects of giving full play to the potential of employees. He said that people are the most precious resource of an enterprise, and everyone has great development potential. The system that conforms to human nature and can most stimulate the potential of employees is the best. A good incentive mechanism should fully stimulate the vitality and passion of the members of the organization and add unlimited creativity to the organization, which can not only solve the pain points of employees' needs, but also enhance the competitiveness of the organization. In order to give full play to the enthusiasm of employees, enterprises should create a comfortable working environment for employees, establish a fair and just evaluation system, and provide growth space and sense of achievement that can continuously create value, so that every contribution of each employee can be affirmed and rewarded in time.
Yu Jianhong said that the improvement of management and the progress of technology are endless. As an industrial enterprise, it is necessary to clarify the assessment and evaluation standards through the decomposition of production and operation responsibilities, establish a communication and interaction mechanism, so that employees can truly participate in the organization. Come to management improvement, participate in on-site technical research, so that enterprises can create the greatest value in unit investment and unit time, this is the ultimate goal of establishing performance appraisal and incentive system. He asked all units to fully learn from the "Amoeba" management philosophy when building a performance appraisal and incentive system, use refined management concepts, and take positive incentives as the leading factor to establish an incentive appraisal system with peak characteristics. Incentive assessment indicators should be scientific, advanced and feasible; adhere to the principles of openness, identity, reciprocity, timeliness and openness; the formulation of standard requirements should be scientific, and the incentive mode and range should be feasible; the incentive assessment standard indicators should be equivalent to the responsibilities undertaken. The magnitude of responsibility should be assessed comprehensively based on the difficulty of the job, the magnitude of the impact on cost and quality, the value of the assets under management, and the safety factor of the various risks. Depending on the actual situation of each enterprise, the performance appraisal mode can be divided into target management responsibility system incentive appraisal centered on target management, operation management responsibility system incentive appraisal centered on realizing profit, economic responsibility system incentive appraisal centered on cost accounting, economic responsibility system incentive appraisal centered on process technology and consumption index (or process cost), marketing responsibility system incentive appraisal centered on sales performance, and project management responsibility system incentive appraisal centered on single project. Assessment, behavior norms as the center of the general responsibility system incentive assessment and other forms. The setting of key performance indicators (
) must conform to the strategic direction and business objectives (especially market objectives) of the enterprise; Due to different types of enterprises, business types, development stages and conditions, and environments, there are also different requirements for the improvement and promotion of performance indicators. Performance indicators should be set by organizing relevant personnel to focus on discussions and other ways, and with the specific implementation of in-depth communication, the basic consensus to determine; to combine the historical optimal indicators, the average indicators of the previous cycle, the advanced indicators of the benchmark unit, the theory should be achieved indicators and personnel, technology, environmental conditions and other factors. The setting of assessment rewards should include not only spiritual rewards such as praise, training, promotion and promotion, but also corresponding material rewards. Yu Jianhong specifically requested that all subordinate enterprises should set up an "honor list" and publicize and praise individual employees and assessment units with outstanding performance every month. Jiang Xiaomeng, chairman of
group company, said in his concluding speech at the exchange meeting that any enterprise or entrepreneur is a product of the times. If you don't continue to arm yourself, no matter how good your performance is, it can only be a temporary event. A good enterprise should have a good sense of direction, each department and unit subject should have clear goals, employees should have a sense of achievement and social responsibility, and win the public's sense of identity. For the peak, through
to today, this year has achieved the best performance in history, but the risks in the future are also increasing. If the management is laissez-faire, the work performance and the enterprise's ability to obtain resources will decline. Therefore, grasping cost, grasping performance and grasping performance is the eternal theme of enterprise management. For performance appraisal, Jiang Xiaomeng requires managers at all levels to achieve "three clears", namely: first, to clarify the appraisal conditions for performance appraisal, to have clear appraisal indicators, complete information, and authoritative appraisal institutions; Second, we must clarify the principles of evaluation, seek truth from facts, highlight the key points, reward the good and punish the bad; third, we must clarify the purpose of evaluation, which is conducive to enhancing the vitality of organizational activities. He asked the participants to bring back the experience and ideas from the exchange meeting, fully digest and absorb them, and effectively improve the performance evaluation work. (Reporter
Fu Yiwu)
More information
The company fully deploys 2018 work
On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-30
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise
On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
The company was rated as an advanced unit of the city's focus on talent and love talent.
News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)
2020
07-31